AGP Picks
View all

Telecommunications Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecommunications Press Releases.

Press releases published on June 29, 2026

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Rogers Communications 2Q26 Investment Community Teleconference July 22, 2026 at 8:00 a.m. ET
Mama’s Creations. Announces Proposed Public Offering of Common Stock
TMD Energy Limited Announces Financial Results for the Six Months Ended December 31, 2025
Beach Day API Launches Real-Time Beach and Ocean Data API for Developers
DHT Holdings, Inc. Announces Fleet Upgrades and Charter Management
Elevra Lithium Breaks Ground on Fully Funded North American Lithium Expansion
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
NeoVolta to Participate in Virtual Fireside Chat Hosted by Needham & Company on June 30, 2026
Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival
Mondia Strengthens Gaming Offering with Ubisoft+ Partnership
Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg
Digital Realty Announces Secondary Offering of Common Stock by Blackstone
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database
Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
TFI International publiera ses résultats du deuxième trimestre de 2026
TFI International to Release Second Quarter 2026 Results
XPO Schedules Second Quarter 2026 Earnings Conference Call for Thursday, July 30, 2026
Nasdaq to Hold Second Quarter 2026 Investor Conference Call
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Telecommunications Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.